Abstract
Since the introduction of plasma exchange as a treatment for Guillain-Barré syndrome (GBS) patients, treatment related fluctuations have been found to occur in about 10% of the patients. These fluctuations are considered additional evidence of the beneficial effect of plasma exchange. In this report the occurrence of such treatment related fluctuations is described in the 147 patients who took part in the Dutch Guillain-Barré trial comparing high dose intravenous immunoglobulin with plasma exchange. Six of 72 patients in the plasma exchange group and eight of 74 in the immunoglobulin group showed such fluctuation. These results support the biological effect of immunoglobulin. More general use of immunoglobulin should await the full analysis of the Dutch GBS trial which is in progress.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Castaigne P., Brunet P., Nouailhat F. Enquête clinique sur les polyradiculonévrites inflammatoires en France. Rev Neurol (Paris) 1966 Oct;115(4):849–872. [PubMed] [Google Scholar]
- Faed J. M., Day B., Pollock M., Taylor P. K., Nukada H., Hammond-Tooke G. D. High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy. Neurology. 1989 Mar;39(3):422–425. doi: 10.1212/wnl.39.3.422. [DOI] [PubMed] [Google Scholar]
- Kennedy R. H., Danielson M. A., Mulder D. W., Kurland L. T. Guillain-Barré syndrome: a 42-year epidemiologic and clinical study. Mayo Clin Proc. 1978 Feb;53(2):93–99. [PubMed] [Google Scholar]
- Kleyweg R. P., van der Meché F. G., Loonen M. C., de Jonge J., Knip B. The natural history of the Guillain-Barré syndrome in 18 children and 50 adults. J Neurol Neurosurg Psychiatry. 1989 Jul;52(7):853–856. doi: 10.1136/jnnp.52.7.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kleyweg R. P., van der Meché F. G., Meulstee J. Treatment of Guillain-Barré syndrome with high-dose gammaglobulin. Neurology. 1988 Oct;38(10):1639–1641. doi: 10.1212/wnl.38.10.1639. [DOI] [PubMed] [Google Scholar]
- Löffel N. B., Rossi L. N., Mumenthaler M., Lütschg J., Ludin H. P. The Landry-Guillain-barré syndrome. Complications, prognosis and natural history in 123 cases. J Neurol Sci. 1977 Aug;33(1-2):71–79. doi: 10.1016/0022-510x(77)90183-6. [DOI] [PubMed] [Google Scholar]
- McCombe P. A., Pollard J. D., McLeod J. G. Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain. 1987 Dec;110(Pt 6):1617–1630. doi: 10.1093/brain/110.6.1617. [DOI] [PubMed] [Google Scholar]
- Osterman P. O., Fagius J., Säfwenberg J., Wikström B. Early relapse of acute inflammatory polyradiculoneuropathy after successful treatment with plasma exchange. Acta Neurol Scand. 1988 Apr;77(4):273–277. doi: 10.1111/j.1600-0404.1988.tb05909.x. [DOI] [PubMed] [Google Scholar]
- Ropper A. E., Albert J. W., Addison R. Limited relapse in Guillain-Barré syndrome after plasma exchange. Arch Neurol. 1988 Mar;45(3):314–315. doi: 10.1001/archneur.1988.00520270096026. [DOI] [PubMed] [Google Scholar]
- Samantray S. K., Johnson S. C., Mathai K. V., Pulimood B. M. Landry-Guillain-Barré-Strohl syndrome. A study of 302 cases. Med J Aust. 1977 Jul 16;2(3):84–91. doi: 10.5694/j.1326-5377.1977.tb99056.x. [DOI] [PubMed] [Google Scholar]
- Vermeulen M., van der Meché F. G., Speelman J. D., Weber A., Busch H. F. Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy. J Neurol Sci. 1985 Oct;70(3):317–326. doi: 10.1016/0022-510x(85)90173-x. [DOI] [PubMed] [Google Scholar]
- Winer J. B., Hughes R. A., Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry. 1988 May;51(5):605–612. doi: 10.1136/jnnp.51.5.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van der Meché F. G., Vermeulen M., Busch H. F. Chronic inflammatory demyelinating polyneuropathy. Conduction failure before and during immunoglobulin or plasma therapy. Brain. 1989 Dec;112(Pt 6):1563–1571. doi: 10.1093/brain/112.6.1563. [DOI] [PubMed] [Google Scholar]